Valuation : ALTEOGEN Inc.

Market Cap 21,690B 15.7B 13.48B 12.62B 11.55B 21.76B 1,499B 21.82B 149B 58.4B 756B 58.94B 57.67B 2,501B P/E 2026 *
73.2x
P/E 2027 * 54.1x
Enterprise Value 21.18B 15.33M 13.16M 12.32M 11.28M 21.25M 1.46B 21.31M 146M 57.03M 738M 57.56M 56.31M 2.44B EV / Sales 2026 *
44x
EV / Sales 2027 * 31.9x
Free-Float
74.26%
Yield 2026 *
0.15%
Yield 2027 * 0.14%
1 day-4.68%
1 week+2.52%
Current month+28.74%
1 month+32.16%
3 months+8.96%
6 months-1.21%
Current year-11.65%
1 week 298,500
Extreme 298500
344,000
1 month 205,000
Extreme 205000
356,000
Current year 194,615.38
Extreme 194615.384615
406,923.08
1 year 194,615.38
Extreme 194615.384615
437,692.31
3 years 32,346.15
Extreme 32346.153846
437,692.31
5 years 21,442.31
Extreme 21442.307691
437,692.31
10 years 2,804.49
Extreme 2804.487177
437,692.31
Manager TitleAgeSince
Chief Executive Officer 61 26/12/2025
Director of Finance/CFO 61 28/03/2023
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 71 13/05/2008
Director/Board Member 70 29/03/2021
Director/Board Member 61 28/03/2023
Date Insider Type Main position Quantity % Market Cap.
21/05/25 Fiscal year

Chief Executive Officer

7,200 0.0135%
27/03/24 Sell 1,600,000 3.0182%
05/01/24 Sell 6,000 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
-4.68%+2.52%-9.33%+752.25% 15.64B
-0.18%-1.60%+38.59%-2.10% 81.36B
-5.78%+6.01%+463.07%+24.16% 59.75B
+0.84%+4.44%-19.19%-35.11% 59.19B
+0.76%+3.53%+0.08%+36.18% 53.33B
+0.41%+1.84%+10.29%+170.02% 49.09B
+0.09%+3.26%+62.32%-16.49% 32.66B
-0.46%+0.20%+50.25%+96.63% 25.97B
-2.00%+9.52%+12.38%+218.34% 24.39B
+0.78%+0.47%+61.53%+123.40% 16.91B
Average -1.02%+0.21%+67.00%+136.73% 41.83B
Weighted average by Cap. -0.87%-0.95%+83.00%+73.20%

Financials

2026 *2027 *
Net sales 481B 348M 299M 280M 256M 482M 33.24B 484M 3.31B 1.29B 16.75B 1.31B 1.28B 55.44B 655B 474M 407M 381M 349M 657M 45.29B 659M 4.51B 1.76B 22.83B 1.78B 1.74B 75.55B
Net income 299B 216M 186M 174M 159M 300M 20.67B 301M 2.06B 805M 10.42B 813M 795M 34.48B 373B 270M 232M 217M 199M 375M 25.8B 376M 2.57B 1.01B 13.01B 1.01B 992M 43.04B
Net Debt -510B -369M -317M -296M -271M -511M -35.23B -513M -3.51B -1.37B -17.75B -1.38B -1.35B -58.76B -765B -553M -475M -445M -407M -767M -52.85B -769M -5.27B -2.06B -26.64B -2.08B -2.03B -88.16B
Logo ALTEOGEN Inc.
Alteogen Inc is a Korea-based company primarily engaged in the research, development, and sales of biopharmaceuticals. The Company develops, produces, and sells biopharmaceuticals, including biobetters and novel biopharmaceuticals, based primarily on hyaluronidase protein engineering technology, sustained-release biopharmaceutical technology, and next-generation antibody-drug conjugate technology. In addition, the Company is engaged in research, development, and commercialization of biosimilars.
Employees
172
Date Price Change Volume
27/08/26 ₩311,500.00 0.00% 368,961
26/08/26 ₩311,500.00 +1.96% 770,565
25/08/26 ₩305,500.00 -4.68% 318,030
24/08/26 ₩320,500.00 +0.16% 376,465
21/08/26 ₩320,000.00 -5.74% 491,494
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
311,500.00KRW
Average target price
372,051.28KRW
Spread / Average Target
+19.44%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A196170 Stock